Jan 20, 2023

Next up for CRISPR: Gene editing for the masses?

Posted by in categories: bioengineering, biotech/medical

Last year, Verve Therapeutics started the first human trial of a CRISPR treatment that could benefit most people—a signal that gene editing may be ready to go mainstream.

Comments are closed.